Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that it has filed an application with a senior stock exchange in the United States to request an uplisting of the Company’s common stock. Lexaria believes it will be positioned to meet the required listing qualifications for the senior […]
The post Lexaria BioScience Files Application with Senior U.S. Stock Exchange for Uplisting appeared first on Technical420.
You may also like
-
Texas Lawmakers Approve New Cannabis Legislation Bill
-
Looking For Top Marijuana ETFs For Q2 2021 Right Now? 2 Leading ETFs To Watch
-
Marijuana Stocks To Watch This Month With Hidden Value
-
Are These Marijuana Penny Stocks A Buy Right Now?
-
Aphria Inc. (APHA) Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination